SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys sharp rally is tied to its multi-year agreement to supply engines, license technology, and provide engineering support to AST SpaceMobile for a new rocket. Traders see the deal as validation of Fireflys engine business and a boost to its backlog, while others question the payment structure, potential dilution, and whether the surge can hold ahead of earnings.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axons Q3 results missed expectations and its outlook was reduced, with traders pointing to delayed federal Dedrone deployments as a key factor. The sharp selloff has sparked debate over whether the reaction is excessive or justified by valuation and execution concerns.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Anticipation around Candels planned FDA BLA for CAN-2409 in localized prostate cancer, following positive Phase 3 results, is driving discussion alongside clinical updates across its pipeline. Bulls focus on the regulatory and commercial potential, while skeptics question filing execution, financing needs and management credibility; traders also attribute recent weakness to broader biotech selling.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Baker Bros reported open-market purchase is driving attention, with bulls treating the added stake as a sign of confidence and fueling short-squeeze talk. Skeptics argue the rally is vulnerable given Kodiaks pre-revenue status and anticipated financing needs, while positive Phase 3 retinal-disease results provide broader pipeline context.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, and Defense. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royces sharp pullback from recent highs is prompting debate over whether the weakness reflects broader market and technology-sector selling, oil and geopolitical concerns, or stock-specific pressure. Many traders view the business fundamentals as intact and are buying the dip while awaiting the upcoming trading update, while others question the stocks continued weakness.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the pending FDA decision on Capricors deramiocel for Duchenne muscular dystrophy, with traders debating HOPE-3 upper-limb data and a physician letter supporting approval. Many expect a favorable decision and speculate about call-driven or short-covering gains, while others emphasize the binary risk of a rejection or another delay.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

Discussion centers on Almontys earnings and the ramp-up at its Sangdong tungsten mine, with traders looking for operational progress and guidance to validate the production story. Reactions are divided: some remain bullish on tight tungsten supply and strategic demand, while others point to earnings disappointment, execution uncertainty, and higher yields as reasons for caution.

Green Thumb Industries, Inc. engages in the manufacture and distribution of branded cannabis products. Its brands include RYTHM, Dogwalkers, Beboe, Good Green, Doctor Solomon’s, and &Shine. It operates through the Retail and Consumer Packaged Goods segments. The Retail segment focuses on retailing cannabis to patients and consumers. The Consumer Packaged Goods segment refers to the cultivation, production, and sale of cannabis products to retail stores. The company was founded by Benjamin Kovler and Max Cohen on February 18, 2002 and is headquartered in Chicago, IL.

Green Thumb Industries Inc - Ordinary Shares (Sub Voting)

Green Thumb Industries

Traders are focused on the DEAs cannabis rescheduling process and the prospect that broader Schedule III treatment could ease 280E tax burdens for U.S. operators; the timing and outcome remain uncertain. Many view Green Thumbs balance sheet and buybacks favorably and are accumulating shares, while others are frustrated by regulatory delays and the stocks lagging performance.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

Discussion centers on Foxconn Tech Day evidence linking POET optical engines to Foxconns high-speed optical networking ecosystem, alongside the appointment of a new CFO and the approaching Q3 results. Bulls view the product visibility as validation and speculate about further orders, while skeptics say a showcase or design win is not proof of scaled shipments and want concrete delivery and revenue updates.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings sharp selloff follows a third-quarter earnings miss and a steeply reduced outlook, with traders focusing on heavy spending to expand its Predictions business as a major drag on near-term profitability. Many criticize management and question whether the investment can compete with Kalshi and Polymarket, while some buyers argue the growing core sportsbook business and potential returns from Predictions justify the pullback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neutral Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	N/A
Prev Close	N/A
Open	N/A
Dividend Yield	N/A
50-Day Moving Average	N/A
Beta	N/A
Avg. Volume	N/A
PE Ratio	N/A

52-Week High	N/A
52-Week Low	N/A
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

EOE Fundamentals